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One Sentence Summary: Comprehensive heritability analysis of brain phenotypes demonstrates a59
clear role for common genetic variation across neurological and psychiatric disorders and60
behavioral-cognitive traits, with substantial overlaps in genetic risk.61
Abstract: Disorders of the brain exhibit considerable epidemiological comorbidity and frequently share62
symptoms, provoking debate about the extent of their etiologic overlap. We quantified the genetic sharing63
of 24 brain disorders and 16 phenotypes based on summary statistics from genome-wide association studies.64
Psychiatric disorders show substantial sharing of common variant risk, while neurological disorders appear65
more distinct from one another. We observe limited evidence of sharing between neurological and66
psychiatric disorders, but do identify sharing between several quantitative measures and brain disorders.67
We also performed extensive simulations to explore power and the impact of diagnostic misclassification68
and phenotypic heterogeneity. These results highlight the importance of common genetic variation as a69
source of risk for brain phenotypes and the value of heritability-based methods in understanding their70
etiology.71
Main Text:72
The classification of brain disorders has evolved over the past century, reflecting the73
medical and scientific communities’ best assessments of the presumed root causes of clinical74
phenomena such as behavioral change, loss of motor function, spontaneous movements or75
alterations of consciousness. A division between neurology and psychiatry developed, with the76
more directly observable phenomena (such as the presence of emboli, protein tangles, or unusual77
electrical activity patterns) generally defining the neurological disorders(1). Applying modern78
methods to understand the genetic underpinnings and categorical distinctions between brain79
disorders may be helpful in informing next steps in the search for the biological pathways that80
underlie their pathophysiology(2, 3).81
In general, brain disorders (here excepting those caused by trauma, infection or cancer)82
show substantial heritability from twin and family studies (4). Epidemiological and twin studies83
have explored patterns of phenotypic overlaps(5-7), and substantial comorbidity has been reported84
for many pairs of disorders, including bipolar disorder-migraine(8), stroke-major depressive85
disorder(MDD)(9), epilepsy-autism spectrum disorders (ASD) and epilepsy-attention deficit86
hyperactivity disorder (ADHD)(10). Furthermore, neurological and psychiatric research has87
shown that mutations in the same ion channel genes confer pleiotropic risk for multiple distinct88
brain phenotypes(11-13). Recently, genome-wide association studies (GWAS) have demonstrated89
that individual common risk variants show overlap across traditional diagnostic boundaries (14,90
315), and that disorders like schizophrenia, MDD and bipolar disorder can have strong genetic91
correlations(16).92
GWAS have also demonstrated that common genetic variation substantially contributes to93
the heritability of brain disorders. In most cases, this occurs via many common variants with small94
risk effects, as has been the case with Alzheimer’s disease(17), bipolar disorder(18), migraine(19),95
Parkinson’s disease(20), and schizophrenia(21). In addition to locus discovery, larger sample sizes96
enable analyses of shared genetic influences, to improve our understanding of the degree of97
distinctiveness of brain disorders(22). Using recently developed heritability-based methods(23)98
we can now extend our evaluation of the nature of these diagnostic boundaries and explore the99
extent of shared common variant genetic influences across a wide set of neurological and100
psychiatric phenotypes.101
102
Study design103
We formed the Brainstorm consortium, a collaboration among GWAS meta-analysis104
consortia of 24 disorders (see Data sources), to perform the first comprehensive heritability and105
correlation analysis of brain disorders. The study sample consists of 212,367 brain disorder cases106
and 647,979 controls (Table 1), including every common brain disorder for which we could107
identify a meta-analysis consortium and reflecting the respective current diagnostic gold standards.108
This includes at least the most common representative in each ICD-10 block in F20-59 (mental109
and behavioral disorders) and G20-G47 (diseases of the central nervous system). Also included110
are 1,113,280 samples for 12 “behavioral-cognitive” phenotypes (n=666,178) chosen for being111
traditionally viewed as brain-related, and four “additional” phenotypes (n=447,102), selected to112
represent known, well-delineated etiological processes (e.g. immune disorders [Crohn’s disease]113
and vascular disease [coronary artery disease]; Table 2).114
GWAS summary statistics for the 40 disorders and phenotypes were centralized and115
underwent uniform quality control and processing(24). We generated European-only meta-116
analyses for each disorder to avoid potential biases arising from ancestry differences, as many of117
the brain disorder datasets included sample sets from diverse ancestries. We have recently118
developed a novel heritability estimation method, linkage disequilibrium score regression119
(LDSC)(23), which was used to calculate heritability estimates and correlations, as well as to120
estimate their statistical significance from block jack-knife-based standard errors. Heritability for121
binary disorders and phenotypes was transformed to liability-scale. We further performed a122
weighted-least squares regression analysis to evaluate whether differences relating to study123
makeup (such as sample size) were correlated with the magnitude of the correlation estimates. We124
also performed a heritability partitioning analysis using stratified LD score regression to examine125
whether the observed heritability was enriched in any tissue-specific regulatory partitions of the126
genome, using the ten top-level tissue-type and 53 functional partitions from Finucane et al. (25).127
4Finally, simulated phenotype data was generated under several different scenarios by permuting128
the 120,267 genotyped individuals from the UK Biobank (24) to both evaluate power and aid in129
interpreting the results (see Supplementary Text).130
131
Heritability and correlations among brain disorders132
We observed a similar range of heritability estimates among the disorders and the133
behavioral-cognitive phenotypes (Fig. S1A-B and Table S1, S2), roughly in line with previously134
reported estimates in smaller datasets (see Table S3 and Supplementary Text). Three ischemic135
stroke subtypes (cardioembolic, large-vessel disease and small-vessel disease) as well as the136
“agreeableness” personality measure from NEO Five-Factor Inventory(26) had insufficient137
evidence for additive heritability for robust analysis and were excluded from further analysis(24).138
We did not observe a correlation between heritability estimates and factors relating to study139
makeup (Table S4; Fig S1C-F).140
In expanding on the number of pairwise comparisons in brain disorders, we observed141
widespread sharing across psychiatric disorders (Fig. 1 and S3) beyond those previously reported142
(16), but not among neurological disorders. Among the psychiatric disorders, schizophrenia in143
particular showed significant genetic correlation with most of the psychiatric disorders. Further,144
schizophrenia, bipolar disorder, anxiety disorders, MDD and ADHD each showed a high degree145
of correlation to the four others (average rg=0.40; Table S5). Anorexia nervosa, OCD and146
schizophrenia also demonstrated significant sharing amongst themselves. Tourette’s syndrome147
(TS) was only significantly correlated with OCD and migraine and not with any of the other148
disorders. From this analysis, the common variant risk of both ASD and TS appear to be somewhat149
distinct from other psychiatric disorders, although with some evidence of correlation between TS150
and OCD and between ASD and schizophrenia. The modest power of the ASD and TS meta-151
analyses, however, limits the strength of this conclusion.152
Neurological disorders revealed greater specificity, and a more limited extent of genetic153
correlation than the psychiatric disorders (Fig. 2 and S4, Table S5). Parkinson’s disease,154
Alzheimer’s disease, generalized epilepsy and multiple sclerosis showed little to no correlation155
with any other brain disorders. Focal epilepsy showed the highest degree of genetic correlation156
among the neurological disorders (average rg =0.46, excluding other epilepsy datasets), though157
none were significant, reflecting the relatively modest power of the current focal epilepsy meta-158
analysis. However, the modest heritability and the broad pattern of sharing observed for focal159
epilepsy may be consistent with considerable heterogeneity and potentially even diagnostic160
misclassification across a range of neurological conditions.161
In the cross-category correlation analysis, the overall pattern is consistent with limited162
sharing across the included neurological and psychiatric disorders (Fig. 3; average rg=0.03). The163
only significant cross-category correlations were with migraine, suggesting it may share some of164
5its genetic architecture with psychiatric disorders; migraine-ADHD (rg=0.26, p=8.81 x 10-8),165
migraine-TS (rg=0.19, p=1.80 x 10-5), and migraine-MDD (rg=0.32, p=1.42 x 10-22 for all166
migraine, rg=0.23, p=5.23 x 10-5 for migraine without aura, rg=0.28, p=1.00 x 10-4 for migraine167
with aura).168
We observed several significant genetic correlations between the behavioral-cognitive or169
additional phenotypes and brain disorders (Fig. 4 and S5, Table S6). Years of education showed a170
significant correlation to each psychiatric disorder (negative for ADHD, anxiety disorders, MDD171
and TS; positive for the others), while five neurological phenotypes (Alzheimer’s disease and the172
four “vascular” phenotypes, intracerebral hemorrhage, all and early-onset stroke and migraine)173
showed a significant negative correlation (Fig. S6; correlations with bipolar disorder(23),174
Alzheimer’s disease and schizophrenia have been previously reported(27)). Among the personality175
measures, significant positive correlations were observed for neuroticism (anxiety disorders,176
migraine, migraine without aura and OCD; Fig. S7), depressive symptoms (ADHD, anxiety177
disorder, bipolar disorder, MDD, and schizophrenia) and subjective well-being (anxiety disorder,178
bipolar disorder, MDD, as well as replicating the previously reported correlation between179
neuroticism with both MDD and schizophrenia(28)). For smoking-related measures, the only180
significant genetic correlations were to never/ever smoked (MDD: rg=0.33, p=3.10 x 10-11 and181
ADHD: rg=0.37, p=3.15 x 10-6).182
Among the additional phenotypes, the two diseases chosen as examples of disorders with183
well-defined etiologies had different results: Crohn’s disease, representing immunological184
pathophysiology, showed no correlation with any of the study phenotypes, while the phenotype185
representing vascular pathophysiology (coronary artery disease) showed significant correlation to186
MDD (rg=0.19, p=8.71 x 10-5) as well as the two stroke-related phenotypes (rg=0.69, p=2.47 x 10-187
6 to ischemic stroke and rg=0.86, p=2.26 x 10-5 for early-onset stroke), suggesting shared genetic188
effects across these phenotype. Significant correlations were also observed for BMI, which was189
positively correlated with ADHD and MDD, and negative correlated with anorexia nervosa (as190
previously reported with a different dataset(23)) and schizophrenia.191
Functional enrichment analysis (Table S7 and S8) replicated the previously reported central192
nervous system (CNS) enrichment for schizophrenia and bipolar disorder (here in a larger dataset193
compared to the original report (25), but with considerable sample overlap). We also demonstrated194
novel significant heritability enrichments to CNS (for generalized epilepsy, MDD, TS, college195
attainment, neuroticism, never/ever smoked) and to immune system cells and tissues (multiple196
sclerosis).197
198
Discussion199
By integrating and analyzing the current genome-wide association summary statistic data200
from consortia of 24 brain disorders, we find that psychiatric disorders broadly share a201
6considerable portion of their common variant genetic risk, especially across schizophrenia, MDD,202
bipolar disorder, anxiety disorder and ADHD, while neurological disorders are more genetically203
distinct. Across categories, psychiatric and neurologic disorders share relatively little of their204
common genetic risk, suggesting that multiple different and largely independently regulated205
etiological pathways may give rise to similar clinical manifestations (e.g., psychosis, which206
manifests in both schizophrenia(29) and Alzheimer’s disease(30)). Except for migraine, which207
appears to share genetic architecture with psychiatric disorders, the existing clinical delineation208
between neurology and psychiatry is recapitulated at the level of common variant risk for the209
studied disorders.210
Given that the broad and continuous nature of psychiatric disorder spectra in particular has211
been clinically recognized for a long time(31-33), we evaluated whether diagnostic212
misclassification (given that genetic correlations are always a function of the underlying213
ascertained phenotypes) could cause the observed correlations. For example, substantial numbers214
of cases progressing through multiple diagnoses over lifetime or some the diagnostic boundaries215
between some phenotype pairs being particularly porous to misclassification, congruent with the216
clinical controversies in classification, could give rise to the appearance of correlation. Previous217
work(34) suggests that even substantial misclassification is likely insufficient to introduce high218
levels of genetic correlation. We expanded on this work by performing a series of simulations219
across a variety of scenarios. These simulations demonstrate that reasonable levels of220
misclassification or changes in the exact level of heritability appear unlikely to induce substantial221
changes in the estimated genetic correlation (Fig. S8, S9, Table S9 and Supplementary Text),222
though the lower resulting heritability (Fig. S8A) would decrease the power to estimate the genetic223
overlap (Fig S10). Further, such evidence of genetic overlap is unlikely to appear in the absence224
of underlying genetic correlation (Table S10), as it is apparent that very high (up to 79%) degree225
of misclassification would be required to produce the observed correlations in the absence of any226
true genetic correlation. Therefore, the observed correlations suggest true sharing of a substantial227
fraction of the common variant genetic architecture among psychiatric disorders as well as between228
behavioral-cognitive measures and brain disorders.229
The high degree of genetic correlation among the psychiatric disorders adds further230
evidence that current clinical diagnostics do not reflect the underlying genetic etiology of these231
disorders, and that genetic risk factors for psychiatric disorders do not respect clinical diagnostic232
boundaries. This suggests an interconnected nature for their genetic etiology, in contrast to233
neurological disorders, and underscores the need to refine psychiatric diagnostics. This study may234
provide important ‘scaffolding’ to support a new research framework for investigating mental235
disorders, incorporating many levels of information to understand basic dimensions of brain236
function, such as through the National Institute of Mental Health’s RDoC initiative.237
The observed positive genetic correlations are consistent with a few different scenarios.238
For example, rg may reflect the existence of some portion of common genetic risk factors239
conferring equal risks to multiple disorders where other distinct additional factors contribute to the240
7eventual clinical presentation. The presence of significant genetic correlation may also reflect the241
phenotypic overlap between any two disorders; for example, the sharing between schizophrenia242
and ADHD might reflect underlying difficulties in executive functioning, which are well-243
established in both disorders(35). Similarly, the sharing between anorexia nervosa, OCD and244
schizophrenia may reflect a shared mechanism underlying cognitive biases that extend from245
overvalued ideas to delusions. Another scenario is that a heritable intermediate trait confers risk to246
multiple outcomes, thereby giving rise to the genetic correlation, as the genetic influences on this247
trait will be shared for both outcomes (e.g., obesity as a risk factor for both type 2 diabetes and248
coronary artery disease), or even that the majority common genetic effects are shared between a249
pair of traits, but each individual effect may confer different degrees of risk and lead to different250
aggregate genetic risk profiles. While a combination of these is likely, it will become increasingly251
feasible to evaluate these overlaps at the locus level in the future as more genome-wide significant252
loci are identified.253
The low correlations observed across neurological disorders suggest that the current254
classification reflects relatively specific genetic etiologies, although the limited sample size for255
some of these disorders and lack of inclusion of disorders conceived as “circuit-based” in the256
literature, such as restless legs syndrome, sleep disorders and possibly essential tremor, constrains257
the generalizability of this conclusion. Generally, this analysis recapitulates the current258
understanding of the relatively distinct primary etiology underlying these disorders; degenerative259
disorders (such as Alzheimer’s and Parkinson’s diseases) would not be expected a priori to share260
their polygenic risk profiles with a neuro-immunological disorder (like multiple sclerosis) or261
neurovascular disorder (like ischemic stroke). Similarly, we see limited evidence for the reported262
co-morbidity between migraine with aura and ischemic stroke(36) (rg=0.29, p=0.099); however,263
the standard errors of this comparison are too high to draw strong conclusions. At the disorder264
subtype level, migraine with and without aura (rg=0.48, p=1.79 x 10-5) show substantial genetic265
correlation, while focal and generalized epilepsy (rg=0.16, p=0.388) show much less.266
The few significant correlations across neurology and psychiatry, namely between267
migraine and ADHD, MDD and TS, suggest modest shared etiological overlap across the268
neurology/psychiatry distinction. The co-morbidity of migraine with MDD and ADHD has been269
previously reported in epidemiological studies (37-39), while in contrast, the previously reported270
co-morbidity between migraine and bipolar disorder seen in epidemiological studies (40) was not271
reflected in our estimate of genetic correlation (rg=-0.03, p=0.406).272
Several phenotypes show only very low-level correlations with any of the other studied273
disorders and phenotypes, despite large sample size and robust evidence for heritability, suggesting274
their common variant genetic risk may largely be unique. Alzheimer’s disease, Parkinson’s275
disease, and multiple sclerosis show extremely limited sharing with the other phenotypes and with276
each other. Neuroinflammation has been implicated in the pathophysiology of each of these277
conditions(41-43), as it has for migraine(44) and schizophrenia(45), but no considerable shared278
heritability was observed with either of those conditions nor with Crohn’s disease. While this279
8observation does not preclude shared neuroinflammatory mechanisms in these disorders, it does280
suggest that on a large scale, common variant genetic influences on these inflammatory281
mechanisms are not shared between the disorders. Further, we only observed significant282
enrichment of heritability to immunological cells and tissues in multiple sclerosis, showing that283
inflammation-specific regulatory marks in the genome do not show overall enrichment for284
common variant risk for either Alzheimer’s or Parkinson’s diseases (though this does not preclude285
the effects of specific, non-polygenic neuroinflammatory mechanisms(46)). Among psychiatric286
disorders, ASD and TS showed a similar absence of correlation with other disorders, although this287
could reflect small sample sizes.288
Analysis of the Big Five personality measures suggests that the current sample sizes for289
personality data are now starting to be sufficiently large for correlation testing; neuroticism, which290
has by far the largest sample size, shows a number of significant correlations. Most significant of291
these was to MDD (rg=0.737, p=5.04 x 10-96), providing further evidence for the link between292
these phenotypes, reported previously with polygenic risk scores(47) and twin studies(48, 49);293
others included schizophrenia, anxiety disorders, migraine, migraine without aura, and OCD294
(Table S6). Further, the observation of strong correlation between MDD and anxiety disorders295
together with their remarkably strong and similar patterns of correlation between each of these296
disorders and the dimensional measures of depressive symptoms, subjective well-being, and297
neuroticism suggests that they all tag a fundamentally similar underlying etiology. The novel298
significant correlation between coronary artery disease and MDD supports the long-standing299
epidemiological observation of a link between MDD and CAD(50), while the observed correlation300
between ADHD and smoking initiation (rg=0.374, p=3.15 x 10-6) is consistent with the301
epidemiological evidence of overlap(51) and findings from twin studies(52), supporting the302
existing hypothesis that impulsivity inherent in ADHD may drive smoking initiation and303
potentially dependence (though other explanations, such as reward system dysfunction would fit304
as well).305
For the neurological disorders, five (Alzheimer’s disease, intracerebral hemorrhage,306
ischemic and early-onset stroke, and migraine) showed significant negative genetic correlation to307
the cognitive measures, while a further two (epilepsy and focal epilepsy) showed moderate308
negative genetic correlation (Fig. S6). For Alzheimer’s disease, poor cognitive performance in309
early life has been linked with increased risk for developing the disorder in later life(53), but to310
our knowledge no such connection has been reported for the other phenotypes. ADHD, anxiety311
disorders and MDD show a significant negative correlation to cognitive and education attainment312
measures, while the remaining five of the eight psychiatric disorders (anorexia nervosa, ASD,313
bipolar disorder, OCD, and schizophrenia) showed significant positive genetic correlation with314
one or more cognitive measures. These results strongly suggest the existence of a link between315
cognitive performance already in early life and the genetic risk for both psychiatric and316
neurological brain disorders. The basis of the genetic correlations between education, cognition317
and brain disorders may have a variety of root causes including, indexing performance differences318
9based on behavioral dysregulation (e.g., ADHD relating to attentional problems during cognitive319
tests) or may reflect ascertainment biases in certain disorders conditional on impaired cognition320
(e.g., individuals with lower cognitive reserve being more rapidly identified for Alzheimer’s321
disease).322
BMI shows significant positive genetic correlation to ADHD, consistent with a meta-323
analysis linking ADHD to obesity(54), and negative genetic correlation with anorexia nervosa,324
OCD and schizophrenia. These results connect well with the evidence for enrichment of BMI325
heritability in CNS tissues(25) and that many reported signals suggest neuronal involvement(55);326
this may also provide a partial genetic explanation for lower BMI in anorexia nervosa patients327
even after recovery(56). Given that no strong correlations were observed between BMI and any of328
the neurological phenotypes, it is possible to hypothesize that BMI’s brain-specific genetic329
architecture is more closely related to behavioral phenotypes. Ischemic stroke and BMI show330
surprisingly little genetic correlation in this analysis (rg=0.07, p=0.26), suggesting that although331
BMI is a strong risk factor for stroke(57), there is little evidence for shared common genetic effects.332
These analyses also suggest that the reported reduced rates of cardiovascular disease in individuals333
with histories of anorexia nervosa (58, 59) are due to BMI-related effects; with the limited evidence334
of genetic correlation of anorexia nervosa with intracerebral hemorrhage, ischemic stroke, early-335
onset stroke and coronary artery disease, these results suggest that any lower cardiovascular336
mortality is more likely due to direct BMI-related effects rather than shared common genetic risk337
variants.338
Broadly it is apparent that the current clinical boundaries for the studied psychiatric339
phenotypes do not appear to reflect distinct underlying pathogenic processes based on the genetic340
evidence, while in contrast, the studied neurological disorders show much greater genetic341
specificity. Although it is important to emphasize that while some disorders are under-represented342
here (e.g. personality disorders in psychiatry and circuit-based disorders such as restless leg343
syndrome in neurology), these results clearly demonstrate the limited evidence for widespread344
common genetic risk sharing between psychiatric and neurological disorders, while on the other345
hand providing strong evidence for links between them and behavioral-cognitive measures. We346
highlight the need for some degree of restructuring of psychiatric nosology and that genetically347
informed analyses may provide a good basis for such activities, consistent with the historical348
knowledge from twin- and family-based results. Further elucidation of individual disorders and349
their genetic overlap, especially as distinct loci map onto a subset of disorders and etiological350
processes, may form the basis for either defining new clinical phenotypes or support a move to a351
more continuous view of psychiatric phenotypes. Ultimately, such developments give hope for352
reducing diagnostic heterogeneity and eventually improving the diagnosis and treatment of353
psychiatric disorders.354
355
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Data sources523
Disorder or phenotype – Consortium or dataset identifier – web address:524
Psychiatric disorders525
ADHD – PGC-ADD2 - http://www.med.unc.edu/pgc/results-and-downloads526
Anorexia nervosa – PGC-ED - http://www.med.unc.edu/pgc/results-and-downloads527
Anxiety disorder – ANGST - http://www.med.unc.edu/pgc/results-and-downloads528
Autism spectrum disorders(16) – PGC-AUT - http://www.med.unc.edu/pgc/results-and-downloads529
Bipolar disorder – PGC-BIP2 - http://www.med.unc.edu/pgc/results-and-downloads (soon)530
Major depressive disorder – PGC-MDD2 - http://www.med.unc.edu/pgc/results-and-downloads (soon)531
OCD – IOCDFGC - https://iocdf.org/532
Schizophrenia(21) – PGC-SCZ2 - http://www.med.unc.edu/pgc/results-and-downloads533
Tourette Syndrome – TSAIGC – http://www.med.unc.edu/pgc/results-and-downloads534
535
Neurological disorders536
Alzheimer's disease(17) – IGAP - http://www.pasteur-lille.fr/en/recherche/u744/igap537
Epilepsy and subtypes, focal and generalized(60) – ILAE – http://www.epigad.org/page/show/gwas_index538
Intracerebral hemorrhage(61) – ISGC - http://www.strokegenetics.com/539
Ischemic stroke and subtypes (cardioembolic, early-onset, small-vessel and large-vessel)(62) – METASTROKE540
dataset of the ISGC – http://www.strokegenetics.com/541
Migraine and subtypes, migraine with and without aura – IHGC – www.headachegenetics.org542
Multiple sclerosis(63) – IMSGC - http://eaglep.case.edu/imsgc_web543
Parkinson's disease(20) – IPDGC – www.pdgene.org544
545
Behavioral-cognitive phenotypes546
College attainment, years of education(64) – SSGAC – http://www.thessgac.org/data547
Childhood cognitive performance(65) – SSGAC – http://www.thessgac.org/data548
Extraversion, agreeableness, conscientiousness and openness (26) – GPC – http://www.tweelingenregister.org/GPC/549
Neuroticism, depressive symptoms and subjective well-being (66) – SSGAC - http://www.thessgac.org/data550
Never/ever smoked, cigarettes per day(67) - TAG - http://www.med.unc.edu/pgc/results-and-downloads551
552
Additional phenotypes553
BMI(55) – GIANT – https://www.broadinstitute.org/collaboration/giant554
Height(68) – GIANT – https://www.broadinstitute.org/collaboration/giant555
556
Crohn’s disease(69) – IIBDGC - http://www.ibdgenetics.org/downloads.html557
Coronary artery disease(70) – Cardiogram – http://www.cardiogramplusc4d.org/downloads/558
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Figure 1. Genetic correlation matrix across psychiatric phenotypes.559
560
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with561
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant562
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder;563
MDD – major depressive disorder; OCD – obsessive-compulsive disorder.564
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Figure 2. Genetic correlation matrix across neurological phenotypes.565
566
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with567
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant568
after Bonferroni correction. Some phenotypes have substantial overlaps (see Table 1), e.g. all cases of generalized569
epilepsy are also cases of epilepsy. Asterisks indicate significant genetic correlation after multiple testing570
correction. ICH – intracerebral hemorrhage.571
572
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Figure 3. Genetic correlation matrix across neurological and psychiatric phenotypes.573
574
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with575
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant576
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder; ICH577
– intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-compulsive disorder.578
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Figure 4. Genetic correlation matrix across brain disorders and behavioral-cognitive phenotypes.579
580
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with581
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant582
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder; ICH583
– intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-compulsive disorder; BMI –584
body-mass index.585
20
Table 1. Brain disorder phenotypes used in the Brainstorm project. Indented phenotypes are part of a larger whole,586
e.g. the epilepsy study consists of the joint analysis of focal epilepsy and generalized epilepsy. Numbers in gray denote587
a sample set which is non-unique, e.g. cardioembolic stroke samples are a subset of ischemic stroke samples. ADHD588
– attention deficit hyperactivity disorder; OCD – obsessive-compulsive disorder. ‘Anxiety disorders’ refers to a meta-589
analysis of five subtypes (generalized anxiety disorder, panic disorder, social phobia, agoraphobia and specific590
phobias). Source details are listed under Data Sources and the references in Table S1.591
592
593
594
Psychiatric disorders Neurological disorders
Disorder Source Cases Controls Disorder Source Cases Controls
ADHD PGC-ADD2 12,645 84,435 Alzheimer's disease IGAP 17,008 37,154
Anorexia nervosa PGC-ED 3,495 11,105 Epilepsy ILAE 7,779 20,439
Anxiety disorders ANGST 5,761 11,765 Focal epilepsy " 4,601 17,985
Autism spectrum disorder PGC-AUT 5,305 5,305 Generalized epilepsy " 2,525 16,244
Bipolar disorder PGC-BIP2 20,352 31,358 Intracerebral hemorrhage ISGC 1,545 1,481
Major depressive disorder PGC-MDD2 16,823 25,632 Ischemic stroke METASTROKE 10,307 19,326
OCD PGC-OCDTS 2,936 7,279 Cardioembolic stroke " 1,859 17,708
Schizophrenia PGC-SCZ2 33,640 43,456 Early-onset stroke " 3,274 11,012
Tourette Syndrome PGC-OCDTS 4,220 8,994 Large-vessel disease " 1,817 17,708
Small-vessel disease " 1,349 17,708
Migraine IHGC 59,673 316,078
Migraine with aura " 6,332 142,817
Migraine without aura " 8,348 136,758
Multiple sclerosis IMSGC 5,545 12,153
Parkinson's disease IPDGC 5,333 12,019
Total psychiatric 105,177 229,329 Total neurologic 107,190 418,650
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Table 2. Behavioral-cognitive and additional phenotypes used in the study. Numbers in gray denote overlapping study595
sets, e.g. samples in the college attainment analysis are a subset of those in the analysis for years of education. (d) –596
dichotomous phenotype, (q) – quantitative phenotype. BMI – body-mass index. Source details are listed under Data597
Sources, while references are listed in Table S2.598
599
600
601
Phenotype Source Samples
Cognitive
Years of education (q) SSGAC 293,723
College attainment (d) " 120,917
Cognitive performance (q) " 17,989
Personality measures
Subjective well-being SSGAC 298,420
Depressive symptoms " 161,460
Neuroticism (q) " 170,911
Extraversion (q) GPC 63,030
Agreeableness (q) " 17,375
Conscientiousness (q) " 17,375
Openness (q) " 17,375
Smoking-related
Never/ever smoked (d) TAG 74,035
Cigarettes per day (q) TAG 38,617
Additional phenotypes
BMI (q) GIANT 339,224
Height (q) " 253,288
Coronary artery disease (d) Cardiogram 86,995
Crohn's disease (d) IIBDGC 20,883
Total 1,124,048
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